Pharmaceuticals & Life Sciences

Speech Recognition & Transcription for Pharmaceuticals & Life Sciences

Speech Recognition & Transcription for pharmaceuticals & life sciences, built around the constraint that defines the sector: GxP validation means every system change needs documented evidence before it reaches production.

Regulations in scope
5
Systems we integrate
5
Typical first release
6 weeks

What changes when it is pharmaceuticals & life sciences

Diarisation matters more than people expect. A transcript that cannot say who spoke is not usable as a record in most professional settings.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how speech recognition & transcription has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is batch record review, usually integrated against QMS. We start from the constraint, not the capability, what the system must never do, who signs off, and what happens when it is wrong.

Deployed across regulated and unregulated sectors, with audit trails where the regulator expects them. We hand over with runbooks, tests and a team that knows how it works, not a dependency.

The sector constraints we design around

Defining constraint
GxP validation means every system change needs documented evidence before it reaches production
Regulations in scope
CDSCO · US FDA 21 CFR Part 11 · EU GMP Annex 11 · GxP validation · ICH guidelines
Systems of record
LIMS · QMS · eTMF · SAP · pharmacovigilance databases
Where we usually start
batch record review

Speech Recognition & Transcription workloads in pharmaceuticals & life sciences

  • batch record review
  • adverse event intake and coding
  • regulatory dossier assembly
  • deviation and CAPA drafting
  • literature monitoring

What is included

  • Domain vocabulary tuning for your terminology
  • Speaker diarisation, who said what
  • Indian language and accent handling, including code-mixing
  • Timestamped output linked to the audio
  • Word error rate measured on your own recordings
  • Integration with your EMR, CRM or case system

Questions from this sector

Can an AI system be GxP validated?

Yes, with a documented validation approach, IQ/OQ/PQ, defined intended use, change control and evidence of consistent performance. We build the validation pack alongside the system, not afterwards.

How do you handle 21 CFR Part 11?

Audit trails, electronic signatures, access control and record integrity designed in from the start, because retrofitting them is effectively a rebuild.

How accurate is it for Indian accents?

Good and improving, but the honest answer depends on audio quality, accent and domain. We benchmark word error rate on your own recordings before you commit.

Can it separate speakers?

Yes, speaker diarisation labels who said what, which is essential for clinical, legal and contact-centre records.

Does the audio leave our environment?

Only if you allow it. We can deploy fully on-premise where confidentiality or regulation requires it.

Speech Recognition & Transcription for pharmaceuticals & life sciences, worth a conversation?

Tell us the workload and the regulation it sits under. We will tell you what is realistic.

Or email bd@dtrasglobal.com · call +91 74118 77878